Pleiotropic effects of statins: Do they matter?

Antonio Gotto, John A. Farmer

Research output: Contribution to journalReview articlepeer-review

77 Scopus citations


Treatment with the 3-hydroxy-3-methylglutaryl coenyzme A reductase inhibitors (or statins) reduces the risk for cardiovascular events across a broad spectrum of patient profiles, as evidenced by both primary prevention and secondary prevention trials. Improved survival by way of reduced deaths from coronary heart disease was also reported with these agents, which are primarily indicated for substantial reduction in LDL-cholesterol levels. However, the statins are extremely complex drugs and exhibit a wide variety of vascular effects that may or may not be dependent on their lipid-modifying properties. These so-called pleiotropic effects include alterations of endothelial function, inflammation, coagulation, and plaque stability. The relative contribution of the nonlipid effects of statin therapy to the well-documented clinical benefits is currently under intense investigation.

Original languageEnglish (US)
Pages (from-to)391-394
Number of pages4
JournalCurrent opinion in lipidology
Issue number4
StatePublished - Aug 4 2001

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Genetics
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine
  • Cell Biology


Dive into the research topics of 'Pleiotropic effects of statins: Do they matter?'. Together they form a unique fingerprint.

Cite this